scieee Open visual document viewer

Antitumoral activity of 1,2-diaminocyclohexane derivatives in breast, colon and skin human cancer cells

Morales, Fátima; Ramirez, A.; Morata-Tarifa, C.; Navarro, S.A.; Marchal, J.A.; Campos, J.M.; Conejo-Garcia, A.

Abstract

Cancer is among the leading causes of death worldwide. Medical interest has focused on macrocyclic polyamines because of their properties as antitumor agents. Results/Methodology: We have designed and synthesized a series of 1,2-diaminocyclohexane derivatives with notable in vitro antiproliferative activities against the MCF-7, HCT-116 and A375 cancer cell lines. Cell cycle and apoptosis analyses were also carried out. Our results show that all the compounds are potent cytotoxic agents, especially against the A375 cell line. Conclusion: The selective activity of the macrocyclic derivative against A375, via apoptosis, supposes a great advantage for future therapeutic use. This exemplifies the potential of 1,2-diaminocyclohexane derivatives to qualify as lead structures for future anticancer drug development due to their easy syntheses and noteworthy bioactivity.

Full text

31/1/2017 An i- umo al Ac i i y o 1, 2‐Diaminocyclohexane De i a i es in B eas , Colon and Skin Human Cance Cells h p://powe xedi o .ap a aco p.com/ sg/Po al/Edi o /Edi o .aspx?asse id=MagMGzL2u%2 s%3d& oleid=TCw3dUK 1OA%3d&edi s a us=1LHEL 8bezw%3d 1/14 DOI: 10.4155/ mc-2016-0212 [Q ue y-Q 1: Ka is hma Bhan( CE) o All(AU)] I is ou hous e s y le o i alic iz e genes o di e en ia e hem om p o eins . Can y ou pleas e c hec k and c on i m ha any genes in y ou a ic le a e i alic iz ed c o ec ly ? Mo ales, Ramí ez, Mo a a-Ta i a e al.[Q ue y- Q 2: Ka is hma Bhan( CE) o All( AU) ] I is ou hous e s y le o lea e all p o eins , genes and g ow h ac o s in hei abb e ia ed o m only . Pleas e c ould y ou ens u e none o hes e ha e been de ined ( inc luding he igu es and ables o a ic les )? An i umo al ac i i y o 1,2‐diaminocyclohexane de i a i es in b eas , colon & skin human cance cells S h o C o m m u n i c a i o n An i umo al ac i i y o 1,2‐diaminocyclohexane de i a i es in b eas , colon and skin human cance cells[Q ue y-Q 3: Ka is hma Bhan( CE) o All(AU)] Pleas e c hec k all au ho names , in pa ic ula y ou c o-au ho ’s names , and a ilia ion de ails a e p es en ed c o ec ly (inc luding in he unning heade a he op o he page) . We will no c hange hes e onc e publis hed in mos c as es . Fá ima Mo ales1, Albe o Ramí ez2,3, Cyn hia Mo a a-Ta i a2,4, Saúl A Na a o2,4, Juan A Ma chal2,4, Joaquín M Campos‡,1,4 & Ana Conejo-Ga cía*,‡,1,4 1Depa amen o de Química Fa macéu ica y O gánica, Facul ad de Fa macia, G anada, Spain [Q ue y- Q 4: Ka is hma Bhan( CE) o All( AU) ] Pleas e p o ide he pos al c odes o a ilia ions 1,2 and 3. 2Ins i u o de Biopa ología y Medicina Regene a i a (IBIMER), Depa amen o de Ana omía y Emb iología Humana, Facul ad de Medicina, G anada, Spain 3Depa amen o de Ciencias de la Salud, Facul ad de Ciencias Expe imen ales y de la Salud, Jaén, Spain 4Ins i u o Biosani a io de G anada (ibs.GRANADA), Hospi ales Uni e si a ios de G anada-Uni e sidad de G anada, 18071, G anada, Spain *Au ho o co espondence: aconejo@ug .es [Q ue y- Q 5: Ka is hma Bhan( CE) o All(AU) ] Pleas e p o ide he elephone and ax numbe o he au ho o co espondence. ‡Au ho s con ibu ed equally Abs ac Aim: Cance is among he leading causes o dea h wo ldwide. Medical in e es has ocused on mac ocyclic polyamines because o hei p ope ies as an i umo agen s. Resul s/Me hodology: We ha e designed and syn hesized a se ies o 1,2‐ diaminocyclohexane de i a i es wi h no able in i o an ip oli e a i e ac i i ies agains he MCF‐7, HCT‐116 and A375 cance cell lines. Cell cycle and apop osis analyses we e also ca ied ou . Ou esul s show ha all he compounds a e po en cy o oxic agen s, especially agains he A375 cell line. Conclusion: The selec i e ac i i y o he mac ocyclic de i a i e agains A375, ia apop osis, supposes a g ea ad an age o u u e he apeu ic use. This exempli ies he po en ial o 1,2‐diaminocyclohexane de i a i es o quali y as lead s uc u es o u u e an icance d ug de elopmen due o hei easy syn heses and no ewo hy bioac i i y. G aphical abs ac 31/1/2017 An i- umo al Ac i i y o 1, 2‐Diaminocyclohexane De i a i es in B eas , Colon and Skin Human Cance Cells h p://powe xedi o .ap a aco p.com/ sg/Po al/Edi o /Edi o .aspx?asse id=MagMGzL2u%2 s%3d& oleid=TCw3dUK 1OA%3d&edi s a us=1LHEL 8bezw%3d 2/14 Keywo ds: 1, 2‐diaminocyclohexanes • an i umo • apop osis • benzenesul onamides • b eas cance • caspases • colon cance • mac ocycles • melanoma Fi s d a submi ed: 11 No embe 2016; Accep ed o publica ion: 4 Janua y 2017; Published online: TBC Cance is among he leading causes o dea h wo ldwide, being esponsible o mo e dea hs han all co ona y hea disease o s oke, accoun ing o 8.2 million dea hs in 2012. I is expec ed ha annual cance cases will ise om 14million in 2012 o 22 wi hin he nex wo decades. Thus, cance con inues o be a majo heal h p oblem in de eloping, as well as unde eloped coun ies [1,2]. The MCF‐7, HCT‐116 and A375 cell lines a e ep esen a i e o b eas , colon and melanoma umo s, espec i ely. B eas cance is he main cance in women bo h in he de eloped and he de eloping coun ies [3], wi h an es ima ed 1.7million new cases and 521,900dea hs in 2012, ep esen ing 25% o all cance diagnoses and 15% o all cance dea hs among emales. MCF‐7 is a luminal epi helial-like cell line ha exp esses low le els o he enzyme phosphodies e ase ype 5 and i s pheno ype is conse ed in hei de i ed umo s [4,5]. Colo ec al cance is a leading cause o cance dea h in de eloped coun ies, being he hi d mos commonly diagnosed cance in men and he second in women, wi h an es ima ed 1.4million cases and 693,900dea hs in 2012 [6]. Colon cance is associa ed wi h a high- equency a ia ion o mic osa elli e epea s as he HCT‐116 cell line shows [7]. A cance -speci ic hype me hyla ion e en o he small nucleola RNAs SNORD123, U70C and ACA59B has ecen ly been ound in his cell line [8]. The incidence o bo h nonmelanoma and melanoma skin cance s has been inc easing o e he pas decades [9], malignan melanoma, being he one ha accoun s o app oxima ely 75% o all dea hs om skin cance [10]. A375 is a human malignan melanoma cell line de i ed om skin biopsies ha is highly umo igenic and me as a ic in animal models [11,12]. Medical in e es has ocused on mac ocyclic polyamines in he las decades because o hei chemical and biological p ope ies as an i umo agen s. Thei an ip oli e a i e ac i i y is due o hei a ini y o he DNA [13]. 1,2‐diamines possess a wide ange o bioac i i ies, such as he an icance and an i ube culosis ones [14]. The amine g oups a e use ul o modula ing he solubili y o he d ug, as well as o dona ing o accep ing hyd ogen bonds o and om a biological ecep o [15]. Diamines (-)- ans-, (+)- ans- and meso‐1 (Figu e 1) showed an ip oli e a i e ac i i y agains he MCF‐7 cell line [16]. They induce g ow h inhibi ion wi h an IC50 o 0.4, 0.6 and 1.8µM, espec i ely. The mos ac i e compound (-)- ans‐1 shows g ea e cy o oxic ac i i y owa d he MCF‐7 cells han he no mal MCF‐10A cells. Real- ime RT-PCR analysis 31/1/2017 An i- umo al Ac i i y o 1, 2‐Diaminocyclohexane De i a i es in B eas , Colon and Skin Human Cance Cells h p://powe xedi o .ap a aco p.com/ sg/Po al/Edi o /Edi o .aspx?asse id=MagMGzL2u%2 s%3d& oleid=TCw3dUK 1OA%3d&edi s a us=1LHEL 8bezw%3d 3/14 demons a ed ha (-)- ans‐1 is an ex emely e icien egula o o he an iapop o ic genes Bcl-xl, Bcl‐2 and cyclin D1. La e s udies o he molecule con i med ha i also egula es p53 [16,17]. Figu e 1. Diamines wi h an ip oli e a i e ac i i y agains he MCF‐7 cell line. Da a aken om [12]. [Q ue y - Q 6: Ka is hma Bhan( CE) o All( AU)] Pleas e c hec k and c on i m ha any igu es / ables ha appea in he a ic le ha e been ed awn c o ec ly , and i no , pleas e des c ibe any c o ec ions ha need o be made. Mac ocyclic compounds ep esen a s uc u al class wi h an excep ional po en ial o biological ac i i y and speci ici y [18]. Nowadays, mac ocycles a e p omising chemo ypes, wi h mo e han 100 ma ke ed mac ocycle d ugs ha included an i umo d ugs [19]. Benzenesul onamides also show an icance ac i i y h ough a a ie y o mechanisms such as cell- cycle pe u ba ion on he G1 phase, he dis up ion o mic o ubule assembly o angiogenesis inhibi ion [20]. We ha e p e iously designed di e en molecules ha a ge cance (Figu e 2). Compound 2 is one o he mos po en human choline kinase inhibi o epo ed o da e, showing ac i i y in he low mic omola ange (IC50=0.3µM) [21], wi h simila alues o o he s ecen ly published [22-24]. Mac ocycle ans-bis(5‐FU O, N-ace al) (3) p esen s an an ip oli e a i e ac i i y o 5.5µM agains he MCF‐7 cell line and p o okes a G0/G1 cell cycle a es in he MCF‐7 b eas cance cells [25]. The benzenesul onamide-con aining compound, named bozepinib (4), is a po en an i umo agen wi h an IC50 agains he MCF‐7 cell line o 0.355µM [26] ha induces apop osis in b eas and colon cance cells. The double- s anded RNA-dependen p o ein kinase PKR is a a ge o bozepinib (4). Mo eo e , he combina ion wi h IFN-α po en ia es he apop osis induced by bozepinib (4) and also enhances au ophagy and senescence, bo h p ocesses o g ea impo ance in umo cells ha show esis ance o con en ional chemo he apy [27]. Bozepinib (4) also shows in i o an i umo and an ime as a ic e icacy in xeno ansplan ed nude mice wi hou p esen ing subacu e oxici y and a selec i e ac i i y agains cance s em cells [28]. Figu e 2. An icance agen s p e iously epo ed by us. In his pape we p esen he syn hesis and biological e alua ion o a se ies o compounds (Figu e 3) designed o s udy he in luence o h ee s uc u al modi ica ions in he 1,2‐diaminocyclohexane de i a i es (1): (A) ansi ion o he phenol 31/1/2017 An i- umo al Ac i i y o 1, 2‐Diaminocyclohexane De i a i es in B eas , Colon and Skin Human Cance Cells h p://powe xedi o .ap a aco p.com/ sg/Po al/Edi o /Edi o .aspx?asse id=MagMGzL2u%2 s%3d& oleid=TCw3dUK 1OA%3d&edi s a us=1LHEL 8bezw%3d 4/14 g oup o me a (m-) and pa a (p-) posi ions (5 and 6, Figu e 3), (B) in oduc ion o wo p-ni obenzenesul onyl g oups (7– 9, Figu e 3) and (C) i s con e sion in o a 14‐membe ed mac ocycle wi h an e hylene b idge ha links he wo phenolic g oups o 1 (10, Figu e 3). [Q ue y -Q 7: Leigh Nugen (PE) o All(AU) ] Wha a e A, B and C e e ing o in he p ec eding s en enc e? Figu e 3. Molecules syn hesized and analyzed as an i umo agen s. Ma e ials & me hods Chemis y Mel ing poin s we e aken in open capilla ies on an elec o he mal mel ing poin appa a us and a e unco ec ed. Analy ical hin laye ch oma og aphy was pe o med using Me ck Kieselgel 60 F254 aluminum shee s, he spo s being de eloped wi h UV ligh (λ=254nm). All e apo a ion was ca ied ou in acuo wi h a Büchi o a y e apo a o and he p essu e con olled by a Vacuub and CVCII appa a us. Fo lash ch oma og aphy, Me ck silica gel 60 wi h a pa icle size o 0.040– 0.063mm (230–400 mesh ASTM) was used. [Q ue y -Q 8: Ka is hma Bhan( CE) o All( AU)] Pleas e de ine he ollowing e m: ‘AST M.’ Pu i y o all compounds was de e mined by NMR s udies, mass spec oscopy and elemen al analysis. [Q ue y -Q 9: Ka is hma Bhan(CE) o All(AU)] Pleas e de ine he ollowing e m: ‘NMR.’ Elemen al analyses we e pe o med on he The mo Scien i ic Flash 2000 analyze and he measu ed alues indica ed by he symbols o he elemen s o unc ions we e wi hin±0.4% o he heo e ical alues. Nuclea magne ic esonance spec a ha e been ca ied ou a he Cen o de Ins umen ación Cien í ica (CIC)/Uni e sidad de G anada and eco ded on a 300MHz 1H and 75MHz 13CNMR Va ian Ino a-TM spec ome e s a ambien empe a u e. Chemical shi s (δ) a e quo ed in pa s pe million (ppm) and a e e e enced o he esidual sol en peak. Signals a e designa ed as ollows: s, single ; bs, b oad single ; d, double ; dd, double double ; ddd, double double double ; , iple ; m, mul iple . High- esolu ion nano-assis ed lase deso p ion/ioniza ion o elec osp ay ioniza ion mass spec a we e ca ied ou on a B uke Au o lex o a Wa e s LCT 31/1/2017 An i- umo al Ac i i y o 1, 2‐Diaminocyclohexane De i a i es in B eas , Colon and Skin Human Cance Cells h p://powe xedi o .ap a aco p.com/ sg/Po al/Edi o /Edi o .aspx?asse id=MagMGzL2u%2 s%3d& oleid=TCw3dUK 1OA%3d&edi s a us=1LHEL 8bezw%3d 5/14 P emie Mass Spec ome e , espec i ely. Anhyd ous CH2Cl2 was pu chased om he VWR In e na ional Eu olab. Anhyd ous condi ions we e pe o med unde a gon. All eagen s we e pu chased om Ald ich. Compounds 1, 5–10 ha e been named acco ding o IUPAC ecommenda ions o phane s uc u es [29,30]. In e media e 11 was syn hesized as p e iously desc ibed [31]. Ta ge compounds meso‐1,5–9, (±)- ans‐1,5–9 and meso‐10 we e syn hesized acco ding o he p e iously epo ed p o ocols [16,32,33] wi h he modi ica ions desc ibed in he Supplemen a y In o ma ion. Biology Cell cul u e MCF‐7 (ECACC: 86012803) and HCT‐116 (ECACC: 91091005) p o ided by he Cell Bank o he Uni e si y o G anada and A375 cells, a gi om Bosse ho (Ins i u e o Pa hology, Regensbu g Uni e si y, Ge many), we e g own a 37°C in an a mosphe e con aining 5% CO2, wi h Dulbecco’s modi ied Eagle Medium (Gibco, NY, USA) supplemen ed wi h 10% hea -inac i a ed e al bo ine se um (Gibco), 2% L-glu amine, 2.7% sodium bica bona e, 1% Hepes bu e , 40 mg/l gen amicin and 500mg/l ampicillin [34-36]. D ug ea men Compounds we e dissol ed in DMSO and s o ed a -20°C. Fo each expe imen , he s ock solu ions we e u he dilu ed in medium o ob ain he desi ed concen a ions. The inal sol en concen a ion in cell cul u e was≤0.1% / o DMSO, a concen a ion wi hou any e ec on cell eplica ion. Pa allel cul u es o MCF‐7, HCT‐116 and A375 cells in medium wi h DMSO we e used as con ols. Biological assays The e ec o he compounds on cell iabili y was assessed using he sul o hodamine-B (SRB) colo ime ic assay. The assay p ocedu e is explained in he supplemen a y in o ma ion ile, as well as he cell-cycle dis ibu ion analysis, he apop osis de ec ion by s aining wi h annexin V-FITC and p opidium iodide and he caspase assay. S a is ical analyses All he quan i a i e da a in he p esen s udy a e epo ed as means±s anda d de i a ion om a leas h ee independen expe imen s. Two-way ANOVA was used o g ouped analysis o di e ences ollowed by Bon e oni pos - es s. Resul s & discussion Chemis y meso- and (±)- ans‐1,5,6 we e syn hesized by educ i e amina ion [16]. The yield o meso‐1 was imp o ed o 100% by inc easing he eac ion ime o he Schi -base condensa ion om 2 o 48h. Sul onyla ion o diamines meso- and (±)- ans‐1,5,6 wi h p-ni obenzenesul onyl chlo ide ga e meso- and (±)- ans‐7,8,9 espec i ely (Figu e 4). [Q ue y - Q 10: Leigh Nugen ( PE) o All( AU)] Pleas e igno e he s pac e below F igu e 5; his will be ec i ied in he inal lay ou . PXE is no ep es en a i e o he inal lay ou , pleas e only us e i o e iew he c on en . 31/1/2017 An i- umo al Ac i i y o 1, 2‐Diaminocyclohexane De i a i es in B eas , Colon and Skin Human Cance Cells h p://powe xedi o .ap a aco p.com/ sg/Po al/Edi o /Edi o .aspx?asse id=MagMGzL2u%2 s%3d& oleid=TCw3dUK 1OA%3d&edi s a us=1LHEL 8bezw%3d 6/14 Figu e 4. Reagen s and condi ions. (A) E 3N/E OH, , 48 h; NaBH4, , 4h [100% o meso‐1, 41% o (±)- ans‐1, 75% o meso‐5, 74% o (±)- ans‐5, 51% o meso‐6, 57% o (±)- ans‐6]; (B) p-NO2-Ph-SO2Cl, anhyd ous CH2Cl2, , 4.5h [63% o meso‐7, 26% o (±)- ans‐7, 24% o meso‐8, 24% o (±)- ans‐8, 16% o meso‐9, 9% o (±)- ans‐9]. The i s s ep in he syn hesis o meso‐10 (Figu e 5) was he eac ion o 1,2‐dib omoe hane wi h salicylaldehyde [31]. The educ i e amina ion o 11 yield meso‐10 wi hou u he pu i ica ion [32,33]. Figu e 5. Reagen s and condi ions. (A) NaOH 2%/E OH, e lux, 72 h (27%); (B) meso‐1,2‐diaminocyclohexane, CH3OH, e lux, 5h; NaBH4, 50°C, 3.5h (38%). Biology Compounds meso‐1, 5–9, (±)- ans‐1, 5–9 and meso‐10 we e assayed o hei in i o an ip oli e a i e ac i i y agains he MCF‐7, HCT‐116 and A375 cell lines. The an i umo d ug oxalipla in, ha con ains a diamine in i s s uc u e, was used as a con ol in he assays and hei IC50 alues a e concu en wi h he ones in li e a u e [37]. The esul s a e 31/1/2017 An i- umo al Ac i i y o 1, 2‐Diaminocyclohexane De i a i es in B eas , Colon and Skin Human Cance Cells h p://powe xedi o .ap a aco p.com/ sg/Po al/Edi o /Edi o .aspx?asse id=MagMGzL2u%2 s%3d& oleid=TCw3dUK 1OA%3d&edi s a us=1LHEL 8bezw%3d 7/14 summa ized in Table 1. All he compounds a e po en an ip oli e a i e agen s wi h he highes po ency agains he A375 melanoma cance cell line (submic omola alues o IC50 o compounds 1, 7–10). meso- and (±)- ans‐1 a e he bes an ip oli e a i e agen s in he h ee cell lines s udied (MCF‐7, HCT‐116 and A375 (IC50=58nM o meso‐1 s 2.5µM o oxalipla in in MCF‐7 cells, IC50 =66 nM o (±)- ans‐1 s 3.8µM o oxalipla in in HCT‐116 cells). [Q ue y -Q 11: Leigh Nugen ( PE) o All( AU) ] Whe e do he b ac k e s be o e MCF - 7 and IC50 end in he p ec eding s en enc e? We should highligh ha he al e a ion o he phenol g oup om o ho (o-) o pa a (p-) posi ion dec eases he an ip oli e a i e ac i i y o compounds 5 (m-) and 6 (p-) subs an ially ( om IC50=0.06–1.2µM o 1 o IC50=10.7–54.6µM o 5 and 6). Howe e , he e is no a di e ence be ween he molecules wi h he p-ni obenzenesul onyl g oup (7–9), whe e he an ip oli e a i e ac i i y is simila be ween o-, m- and p- de i a i es (IC50 = 0.94–6.3µM). The bes alues o an ip oli e a i e ac i i y o he p- ni obenzenesul onyl de i a i es a e meso‐9 agains HCT‐116 cell line (IC50=1.1µM) and (±)- ans‐9 agains A375 cell line (IC50=94nM). meso‐10 shows simila alues o an ip oli e a i e ac i i y as oxalipla in agains he MCF‐7 cell line (IC50=2.9, 2.5µM, espec i ely), being a be e agen han oxalipla in agains HCT‐116 and A375 cell lines (IC50=1.5, 1.1µM agains 3.8, 3.4µM, espec i ely). As a esul , we should men ion ha he modi ica ion o he phenol g oups in compounds 5 and 6, he in oduc ion o he p-ni obenzenesul onyl g oup in o meso- and (±)- ans‐1 o gi e meso- and (±)- ans‐7–9 as well as he mac ocycliza ion o p oduce meso‐10, do no imp o e he an ip oli e a i e ac i i y in ela ion o hose o meso- and (±)- ans‐1. Table 1. An ip oli e a i e ac i i y o meso- and (±)- ans‐1,5–9, meso‐10 and oxalipla in agains he MCF‐7, HCT‐116 and A375 cell lines. Compound MCF‐7 IC50µM HCT‐116 IC50µM A375 IC50µM meso‐10.058±0.014 0.236±0.060 0.099±0.018 (±)- ans‐11.240±0.018 0.066±0.017 0.205±0.015 meso‐542.30±0.012 12.79±1.08 40.30±1.01 (±)- ans‐548,40±0.76 14.84±0.12 35.65±0.92 meso‐654.56±1.16 31.30±0.92 38.70±1.32 (±)- ans‐640.90±0.78 10.65±0.82 32.18±0.69 meso‐77.010±0.044 5.070±0.032 3.413±0.016 (±)- ans‐72.630±0.044 3.680±0.045 2.398±0.020 meso‐86.320±0.011 5.040±0.005 2.040±0.001 (±)- ans‐86.100±0.047 4.390±0.010 2.030±0.001 meso‐94.130±0.014 1.090±0.007 4.390±0.019 (±)- ans‐94.080±0.024 4.330±0.002 0.940±0.003 meso‐10 2.900±0.018 1.460±0.001 1.106±0.064 Oxalipla in 2.500±0.003 3.770±0.001 3.350±0.002 All expe imen s we e conduc ed in iplica e and ga e simila esul s. Da a a e he mean±SD o h ee independen de e mina ions. µM: Mic omola . The cell cycle is he p ocess by which cells duplica e hemsel es, g ow and p epa e o di ide again. I egula es cell di ision in mul icellula o ganisms and i is essen ial o he eplacemen o damaged cells. Regula ion o cell p oli e a ion 31/1/2017 An i- umo al Ac i i y o 1, 2‐Diaminocyclohexane De i a i es in B eas , Colon and Skin Human Cance Cells h p://powe xedi o .ap a aco p.com/ sg/Po al/Edi o /Edi o .aspx?asse id=MagMGzL2u%2 s%3d& oleid=TCw3dUK 1OA%3d&edi s a us=1LHEL 8bezw%3d 8/14 is one o he s a egies o he ea men o cance . As a consequence, in o de o e alua e whe he he an ip oli e a i e e ec o hese molecules in ol es changes in cell-cycle dis ibu ion, A375 cells we e ea ed wi h he compounds ha p esen be e an ip oli e a i e ac i i y: 1, 7–10 and hen analyzed by low cy ome y (see Table 2). We ound a cell- cycle a es in he G0/G1 phase induced by meso- and (±)- ans‐7 and 9 and meso‐10. meso‐1 and meso and (±)- ans‐8 did no modi y he cell cycle p o ile and (±)- ans‐1 p o oked a G2/M and S-phase cell-cycle a es a he expense o G0/G1 phase. The an ip oli e a i e p ope ies o se e al an i umo agen s a e media ed by he modula ion o cell-cycle checkpoin . Palbociclib is an inhibi o o CDK4 and CDK6 ha p o okes a p onounced G0/G1 a es , as molecules 7,9 and 10. I is a highly selec i e and o ally ac i e d ug, blocking e inoblas oma phospho yla ion in a low nanomola ange [38]. I s an i umo ac i i y is associa ed wi h educed Rb phospho yla ion and wi h a dec eased exp ession o Ki‐67 [39], a cell p oli e a ion ma ke ha is associa ed wi h ibosomal RNA ansc ip ion. I dec eased caspase 3/7 ac i a ion and CDKN2A and inc eased le els o RB1 and cyclin D1 [40]. An example o a d ug ha causes cell-cycle G2/M a es , as (±)- ans‐1, is panobinos a [41-43]. I is demons a ed ha i dec eases in i o umo igenesis o iple-nega i e b eas cance cells. Panobinos a is a po en inhibi o wi h ac i i y agains Class I, II and IV HDAC enzymes, wi h hype ace yla ion o his ones H3 (Lys9) and H4 (Lys8) [41]. Table 2. Cell cycle analysis in he A375 melanoma cell line upon ea men wi h meso- and (±)- ans‐ 1,7–9, meso‐10 compounds and oxalipla in (a 3×IC50 doses, 48h). Compound Cell cycle G0/G1SG2/M Con ol 38.97±0.22 44.42±0.66 16.61±0.45 meso‐139.04±1.63 42.24±2.98 18.73±1.35 (±)- ans‐119.97±0.13 54.78±1.95 25.26±1.83 meso‐758.01±0.36 30.14±0.24 11.85±0.11 (±)- ans‐762.28±0.14 28.54±1.33 9.19±1.20 meso‐838.95±2.69 46.90±2.62 14.15±1.70 (±)- ans‐836.68±1.91 50.40±0.14 12.93±0.92 meso‐955.63±1.98 36.56±1.20 7.79±0.28 (±)- ans‐942.35±0.99 44.16±0.64 13.49±0.57 meso‐10 66.97±3.59 15.22±1.05 17.82±4.63 Oxalipla in 53.15±0.71 30.22±0.85 16.62±0.42 De e mined by low cy ome y [44]. All expe imen s we e conduc ed in iplica e and ga e simila esul s. Da a a e he mean±SD o h ee independen de e mina ions. Fu he s udies we e pe o med o de e mina e i he obse ed g ow h inhibi ion was due o apop osis. Apop osis is a gene ic o de ly p ocess in which cells lead o hei own dea h in esponse o di e en s imuli and i is an essen ial p ocess o main ain homeos asis in mul icellula o ganisms. The e o e, apop osis ac i a ion is a undamen al s a egy in he imp o emen o cance he apy. Apop osis was de e mined using an Annexin V-based assay in A375 cells ea ed wi h compounds: 1, 7–10 (see Supplemen a y Table 1). A ligh apop o ic esponse was obse ed by compound (±)- ans‐7 (28.3%) and no signi ican esponse by molecules 1-, meso‐7 and 9 (6.35–14.91%). Howe e , we can emphasize ha †‡ † ‡ 31/1/2017 An i- umo al Ac i i y o 1, 2‐Diaminocyclohexane De i a i es in B eas , Colon and Skin Human Cance Cells h p://powe xedi o .ap a aco p.com/ sg/Po al/Edi o /Edi o .aspx?asse id=MagMGzL2u%2 s%3d& oleid=TCw3dUK 1OA%3d&edi s a us=1LHEL 8bezw%3d 9/14 he mac ocycle meso‐10, which is he compound ha induces mo e G0/G1 phase accumula ion, is also he d ug ha p o okes ex emely high le els o apop osis a 48h in he A375 cance cells. This compound inc eases he pe cen age o apop o ic cells (ea ly and la e apop osis) om 1.05% in DMSO- ea ed cells o 95.0%. Highly apop o ic d ugs ha e demons a ed e icien an i umo ac i i ies in pa ien s. The po en apop o ic p ope ies o he mac ocycle meso‐10 in melanoma cells sugges he po en ial clinical in e es o his d ug and encou age u u e deep s udies and in i o expe imen s. Finally, s udies o apop osis we e pe o med by he ac i a ion o caspases o de e mine which me abolic pa hway ac i a ed hese d ugs. Compound meso‐10 (Figu e 6) ac i a es he canonical in insic caspase‐8/caspase‐3 apop o ic pa hway on he MCF‐7 cell line, bu also his compound induces sligh ly caspase‐2 ac i a ion (Figu e 6A). Howe e , his compound does no signi ican ly ac i a e signi ican ly any caspase in HCT‐116 and A‐375 cell lines (Figu es 4B &C). Di e en cell dea h modali ies exposed o he same molecule in di e se cell lines ha e been p e iously desc ibed [45]. Indi ubin, a CDK inhibi o , induces caspase-independen cell dea h in human neu oblas oma [46], while o he indi ubin de i a i es induce cell dea h h ough he in insic caspase‐9 pa hway and/o ac i a ion o caspase‐8 in b eas cance cells [47].